Evaluate Pembrolizumab (Keytruda): CADTH Reimbursement Suggestion: Sign: In combination with chemotherapy, for that treatment of adult patients with locally recurrent unresectable or metastatic triple-damaging breast most cancers which have not been given prior chemotherapy for metastatic disease and whose tumours Specific programmed cell death-ligand one (combined optimistic score ≥ ... https://pembrolizumab-cost59370.shotblogs.com/new-step-by-step-map-for-pembrolizumab-cost-49994625